Brief: Pharmaust Ltd Says Chief Executive Officer Michael Thurn, Has Tendered His Resignation
23/04/2024 02:15
April 23 (Reuters) - Pharmaust Ltd PAA.AX :
* CHIEF EXECUTIVE OFFICER DR MICHAEL THURN, HAS TENDERED HIS
RESIGNATION
* JOHN CLARK APPOINTED INTERIM CEO.
Further company coverage: PAA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon Therapeutics jumps on deal with US firm
Brief: Neurizon Therapeutics Executes Long-Term Supply Agreement With Elanco
Brief: Neurizon Therapeutics Receives Ethics Approval For Phase 1 Nuz-001 Oral Liquid Formulation Study
Brief: Neurizon Therapeutics Announces Placement Of Entitlement Offer Shortfall To Raise ~A$2.7 Million
Brief: Neurizon Therapeutics Says Michael Thurn Resigns As Managing Director And CEO